Yong Mou

755 total citations
22 papers, 513 citations indexed

About

Yong Mou is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Yong Mou has authored 22 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Yong Mou's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Cancer-related molecular mechanisms research (5 papers) and IL-33, ST2, and ILC Pathways (3 papers). Yong Mou is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Cancer-related molecular mechanisms research (5 papers) and IL-33, ST2, and ILC Pathways (3 papers). Yong Mou collaborates with scholars based in China, United States and Greece. Yong Mou's co-authors include Yi Wang, Yongjian Xu, Weining Xiong, Jun Yu, Lei Zhang, Kang Miao, Jianping Zhao, Zhen‐Li Huang, Bohua Fu and Ting Pan and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Oncotarget and Biomedicine & Pharmacotherapy.

In The Last Decade

Yong Mou

22 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yong Mou China 12 261 201 169 52 44 22 513
Xian-Ying Zhu China 7 340 1.3× 357 1.8× 249 1.5× 51 1.0× 37 0.8× 14 567
Andrea E. Calvert United States 10 257 1.0× 148 0.7× 167 1.0× 52 1.0× 26 0.6× 17 460
Jie Ju China 13 423 1.6× 140 0.7× 249 1.5× 51 1.0× 38 0.9× 23 553
Ruizhi Wang China 9 238 0.9× 109 0.5× 109 0.6× 37 0.7× 72 1.6× 17 436
Lisi Zheng China 11 382 1.5× 230 1.1× 242 1.4× 62 1.2× 33 0.8× 16 597
Meirong Shan China 8 204 0.8× 148 0.7× 161 1.0× 60 1.2× 22 0.5× 10 386
Xiuling Li China 14 228 0.9× 82 0.4× 145 0.9× 48 0.9× 55 1.3× 29 468
Jianzhuang Ren China 12 180 0.7× 88 0.4× 102 0.6× 46 0.9× 26 0.6× 26 401
Zhenkun Xia China 12 238 0.9× 54 0.3× 114 0.7× 66 1.3× 44 1.0× 34 407
Liangcai Hou China 10 349 1.3× 208 1.0× 255 1.5× 61 1.2× 28 0.6× 18 579

Countries citing papers authored by Yong Mou

Since Specialization
Citations

This map shows the geographic impact of Yong Mou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Mou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Mou more than expected).

Fields of papers citing papers by Yong Mou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Mou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Mou. The network helps show where Yong Mou may publish in the future.

Co-authorship network of co-authors of Yong Mou

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Mou. A scholar is included among the top collaborators of Yong Mou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Mou. Yong Mou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mou, Yong, Ping Wu, Ke Wang, et al.. (2025). Association between magnesium depletion score and prevalence of hyperuricemia in American adults: a study based on NHANES 2007-2018. Frontiers in Endocrinology. 16. 1438639–1438639. 1 indexed citations
2.
Mou, Yong, et al.. (2024). The causality between C-reactive protein and asthma: a two-sample Mendelian randomization analysis. Postgraduate Medical Journal. 100(1186). 555–561. 3 indexed citations
3.
Mou, Yong, Juan Liu, Ting Pan, et al.. (2021). Dopamine receptor agonists ameliorate bleomycin-induced pulmonary fibrosis by repressing fibroblast differentiation and proliferation. Biomedicine & Pharmacotherapy. 139. 111500–111500. 9 indexed citations
4.
Mou, Yong, Guorao Wu, Qi Wang, et al.. (2021). Macrophage‐targeted delivery of siRNA to silence Mecp2 gene expression attenuates pulmonary fibrosis. Bioengineering & Translational Medicine. 7(2). e10280–e10280. 23 indexed citations
5.
Zhu, Jing, et al.. (2021). Identification of a Six-Gene SLC Family Signature With Prognostic Value in Patients With Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology. 9. 803198–803198. 9 indexed citations
6.
Liu, Peng, Kang Miao, Lei Zhang, et al.. (2020). Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation. Respiratory Research. 21(1). 58–58. 67 indexed citations
7.
Xu, Yuzhu, Jun Yu, Zhen‐Li Huang, et al.. (2020). Circular RNA hsa_circ_0000326 acts as a miR-338-3p sponge to facilitate lung adenocarcinoma progression. Journal of Experimental & Clinical Cancer Research. 39(1). 57–57. 56 indexed citations
8.
Wang, Qi, Jun Yu, Yinan Hu, et al.. (2020). Indirubin alleviates bleomycin-induced pulmonary fibrosis in mice by suppressing fibroblast to myofibroblast differentiation. Biomedicine & Pharmacotherapy. 131. 110715–110715. 30 indexed citations
9.
Wu, Shimin, Li Peng, Yong Mou, et al.. (2020). Advanced pneumonic type of lung adenocarcinoma: survival predictors and treatment efficacy of the tumor. Tumori Journal. 107(3). 216–225. 5 indexed citations
10.
Huang, Zhen‐Li, Bohua Fu, Yuzhu Xu, et al.. (2020). Diagnostic and Therapeutic Value of Hsa_circ_0002594 for T Helper 2-Mediated Allergic Asthma. International Archives of Allergy and Immunology. 182(5). 388–398. 18 indexed citations
11.
Zhao, Peng, et al.. (2020). [Anterolateral femoral flap combined with fascia lata grafting for repair large Achilles tendon and skin defects].. PubMed. 34(12). 1585–1589. 1 indexed citations
12.
Miao, Kang, Ting Pan, Yong Mou, et al.. (2020). Scutellarein inhibits BLM-mediated pulmonary fibrosis by affecting fibroblast differentiation, proliferation, and apoptosis. Therapeutic Advances in Chronic Disease. 11. 1754231961–1754231961. 45 indexed citations
13.
Chen, Huilong, Bohua Fu, Zhen‐Li Huang, et al.. (2019). <p>LncRNAs NR-026690 and ENST00000447867 are upregulated in CD4<sup>+</sup> T cells in patients with acute exacerbation of COPD</p>. International Journal of COPD. Volume 14. 699–711. 12 indexed citations
14.
Wang, Yang, Ji Zhang, Fuhua Lin, et al.. (2018). Outcome and prognostic value of treatment for brain metastases and the primary tumor in patients with breast cancer brain metastases. Clinical Neurology and Neurosurgery. 170. 43–46. 3 indexed citations
15.
Tian, Kunming, Panpan Chen, Zhiping Liu, et al.. (2017). Sirtuin 6 inhibits epithelial to mesenchymal transition during idiopathic pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling. Oncotarget. 8(37). 61011–61024. 35 indexed citations
16.
17.
Huang, Dong, et al.. (2016). MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1. Medical Science Monitor. 22. 1761–1765. 41 indexed citations
18.
Huang, Dong, et al.. (2014). Mechanical compression upregulates MMP9 through SMAD3 but not SMAD2 modulation in hypertrophic scar fibroblasts. Connective Tissue Research. 55(5-6). 391–396. 19 indexed citations
19.
Yang, Qun, Dong Shen, Ke Sai, et al.. (2013). [Survival of newly diagnosed malignant glioma patients on combined modality therapy].. PubMed. 93(1). 8–10. 3 indexed citations
20.
Jiang, Xiao, et al.. (2011). [Correlation between TGF- β1 expression and Treg cell infiltration in glioma].. PubMed. 27(6). 680–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xian-Ying Zhu Breakdown of academic impact, for papers by Andrea E. Calvert Breakdown of academic impact, for papers by Jie Ju Breakdown of academic impact, for papers by Ruizhi Wang Breakdown of academic impact, for papers by Lisi Zheng Breakdown of academic impact, for papers by Meirong Shan Breakdown of academic impact, for papers by Xiuling Li Breakdown of academic impact, for papers by Jianzhuang Ren Breakdown of academic impact, for papers by Zhenkun Xia Breakdown of academic impact, for papers by Liangcai Hou
Rankless by CCL
2026